119 related articles for article (PubMed ID: 30187810)
1. A rare MYC/BCL3 double-translocation and protein-expression in a diffuse large B-cell lymphoma.
Ohno H; Nakagawa M; Kishimori C; Fukutsuka K; Hayashida M; Izumi K; Akasaka T; Honjo G; Haga H
Leuk Lymphoma; 2019 Mar; 60(3):825-828. PubMed ID: 30187810
[No Abstract] [Full Text] [Related]
2. Double-hit vitreoretinal lymphoma.
Or C; Kirker AW; Rasmussen S; Villa D; Gerrie AS; Forooghian F
Can J Ophthalmol; 2014 Jun; 49(3):e73-6. PubMed ID: 24862789
[No Abstract] [Full Text] [Related]
3. [Significance and application of c-myc in diffuse large B-cell lymphoma].
Huang WT; Lü N; Guo L
Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):638-40. PubMed ID: 24314257
[No Abstract] [Full Text] [Related]
4. Primary sacral non-germinal center type diffuse large B-cell lymphoma with MYC translocation: a case report and a review of the literature.
Shimada A; Sugimoto KJ; Wakabayashi M; Imai H; Sekiguchi Y; Nakamura N; Sawada T; Ota Y; Komatsu N; Noguchi M
Int J Clin Exp Pathol; 2013; 6(9):1919-28. PubMed ID: 24040459
[TBL] [Abstract][Full Text] [Related]
5. [Survival of patients with primary central nervous system diffuse large B-cell lymphoma: impact of gene aberrations and protein overexpression of bcl-2 and C-MYC, and selection of chemotherapy regimens].
Yin WJ; Zhu X; Yang HY; Sun WY; Wu MJ
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):32-38. PubMed ID: 29325248
[No Abstract] [Full Text] [Related]
6. Clinical significance of 'double-hit' and 'double-expression' lymphomas.
Ma Z; Niu J; Cao Y; Pang X; Cui W; Zhang W; Li X
J Clin Pathol; 2020 Mar; 73(3):126-138. PubMed ID: 31615842
[TBL] [Abstract][Full Text] [Related]
7. Clinical Significance of
Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS
Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907
[No Abstract] [Full Text] [Related]
8. [Clinical characteristics and prognosis of concurrent positive t(14; 18) and myc gene rearrangement in diffuse large B cell lymphoma].
Zhang HW; Chen ZW; Wang LY; He JX; Zheng YP; Han WE; Yang B; Wang YL; Zhao ZQ; Bai M; Su LP
Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):206-10. PubMed ID: 26988827
[TBL] [Abstract][Full Text] [Related]
9. The novel double-hit, t(8;22)(q24;q11)/MYC-IGL and t(14;15)(q32;q24)/IGH-BCL2A1, in diffuse large B-cell lymphoma.
Akasaka T; Kishimori C; Fukutsuka K; Nakagawa M; Takeoka K; Hayashida M; Honjo G; Ohno H
Cancer Genet; 2017 Aug; 214-215():26-31. PubMed ID: 28595732
[TBL] [Abstract][Full Text] [Related]
10. Pediatric ALK+ anaplastic large cell lymphoma with t(3;8)(q26.2;q24) translocation and c-myc rearrangement terminating in a leukemic phase.
Monaco S; Tsao L; Murty VV; Nandula SV; Donovan V; Oesterheld J; Bhagat G; Alobeid B
Am J Hematol; 2007 Jan; 82(1):59-64. PubMed ID: 16955462
[TBL] [Abstract][Full Text] [Related]
11. Double-Hit Lymphoma.
Goyal G; Caponetti GC; Silberstein PT
J Clin Exp Hematop; 2015; 55(1):51-3. PubMed ID: 26106008
[No Abstract] [Full Text] [Related]
12. [Correlation between C-MYC protein expression and genetic abnormalities in diffuse large B-cell lymphoma].
Yu H; Wang H; Zhang N; Gao SM; Zhang YX
Zhonghua Bing Li Xue Za Zhi; 2018 Mar; 47(3):172-175. PubMed ID: 29534355
[No Abstract] [Full Text] [Related]
13. Primary Cutaneous Diffuse Large B-Cell Lymphoma With a MYC-IGH Rearrangement and Gain of BCL2: Expanding the Spectrum of MYC/BCL2 Double-Hit Lymphomas.
Testo N; Olson LC; Subramaniyam S; Hanson T; Magro CM
Am J Dermatopathol; 2016 Oct; 38(10):769-74. PubMed ID: 27391453
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
Green TM; Young KH; Visco C; Xu-Monette ZY; Orazi A; Go RS; Nielsen O; Gadeberg OV; Mourits-Andersen T; Frederiksen M; Pedersen LM; Møller MB
J Clin Oncol; 2012 Oct; 30(28):3460-7. PubMed ID: 22665537
[TBL] [Abstract][Full Text] [Related]
15. Real world data on young patients with high-risk diffuse large B-cell lymphoma treated with R-CHOP or R-CHOEP - MYC, BCL2 and BCL6 as prognostic biomarkers.
Pedersen MØ; Gang AO; Brown P; Pedersen M; Knudsen H; Nielsen SL; Poulsen T; Wirenfeldt Klausen T; Høgdall E; Nørgaard P
PLoS One; 2017; 12(10):e0186983. PubMed ID: 29088292
[TBL] [Abstract][Full Text] [Related]
16. [B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].
Luo DL; Liu YH; Zhang F; Xu FP; Yan LX; Chen J; Xu J; Luo XL; Zhuang HG
Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):584-8. PubMed ID: 24314242
[TBL] [Abstract][Full Text] [Related]
17. Dual expression of MYC and BCL2 proteins predicts worse outcomes in diffuse large B-cell lymphoma.
Clark Schneider KM; Banks PM; Collie AM; Lanigan CP; Manilich E; Durkin LM; Hill BT; Hsi ED
Leuk Lymphoma; 2016 Jul; 57(7):1640-8. PubMed ID: 26421520
[TBL] [Abstract][Full Text] [Related]
18. An aggressive "double-hit" lymphoma occurring in a 42-year-old male with both MYC and t(14;18) translocations.
Laudenschlager MD; Geis MC
S D Med; 2010 Sep; 63(9):311-3, 315. PubMed ID: 20860118
[TBL] [Abstract][Full Text] [Related]
19. De novo B lymphoblastic leukemia/lymphoma in an adult with t(14;18)(q32;q21) and c-MYC gene rearrangement involving 10p13.
Subramaniyam S; Fraser CR; Rao PH; Feldman E; Ely S; Mathew S
Leuk Lymphoma; 2011 Nov; 52(11):2195-9. PubMed ID: 21718139
[No Abstract] [Full Text] [Related]
20. Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma.
Stasik CJ; Nitta H; Zhang W; Mosher CH; Cook JR; Tubbs RR; Unger JM; Brooks TA; Persky DO; Wilkinson ST; Grogan TM; Rimsza LM
Haematologica; 2010 Apr; 95(4):597-603. PubMed ID: 20378577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
